United States of America v. Humana Inc

CourtDistrict Court, W.D. Kentucky
DecidedJanuary 31, 2023
Docket3:18-cv-00061
StatusUnknown

This text of United States of America v. Humana Inc (United States of America v. Humana Inc) is published on Counsel Stack Legal Research, covering District Court, W.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America v. Humana Inc, (W.D. Ky. 2023).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF KENTUCKY LOUISVILLE DIVISION CIVIL ACTION NO. 3:18-CV-00061-GNS-CHL

UNITED STATES OF AMERICA, ex rel. Steven Scott, Plaintiff,

v.

HUMANA, INC., Defendant.

MEMORANDUM OPINION AND ORDER Before the Court is the motion for a protective order regarding the supplemental deposition of Richard Foster filed by Plaintiff-Relator Steven Scott (“Relator”). (DN 513.) Accompanying this motion is Relator’s unopposed motion to extend the deadline for the supplemental deposition of Richard Foster. (DN 514.) Defendant Humana, Inc. (“Humana”) filed its response in opposition (DN 520), to which Relator filed a reply. (DN 522.) Therefore, this matter is ripe for review. For the reasons set forth herein, Relator’s Motion for a Protective Order (DN 513) is DENIED. I. BACKGROUND Relator brought this False Claims Act (“FCA”) action alleging that Humana submitted bids based on knowingly false actuarial assumptions for its prescription drug plan to the Centers for Medicare & Medicaid Services (“CMS”), resulting in overpayments from CMS to Humana. (DN 1.) In June 2018, Relator retained former Chief Actuary of CMS, Richard Foster (“Foster”), as a consulting expert. (DN 410 at 45866.) In “late 2018,” Relator retained Foster to provide additional service as a testifying expert witness on the specific issue of Humana’s materiality defense. (DN 379-11 at 42858; DN 474 at 65043.) On April 21, 2020, Relator produced Foster’s expert report. 1 (DN 379 at 42736.) On June 15, 2020, Relator produced Foster’s rebuttal report. (DN 379-13.) On July 17, 2020, Foster sat for his deposition. (DN 379-11.) During the deposition, Humana learned that Foster had participated in several meetings with DOJ and CMS employees in 2018 and 2019 and exchanged follow up emails about discussions during the meetings. (Id. at 42863, 42866.) These communications were not included in Relator’s privilege log. (DN 379-14 at

42948.) When questioned about the nature of the meetings, counsel for Relator instructed Foster not to answer on the basis that Foster’s communications with CMS and the DOJ concerning this case are privileged. (DN 379-11 at 42861-62, 42865-66.) On July 31, 2020, Humana contacted Relator requesting production of communications between Relator and CMS, asserting that Relator failed to produce the correspondence with CMS or list them in his privilege long despite the communications being responsive to Humana’s prior discovery requests. (DN 379-14 at 42949.) Humana further requested production of any documents Relator provided to the DOJ and CMS in connection with the meetings discussed during Foster’s deposition. (Id.) On August 4, 2020, Relator claimed in response that Foster’s

communications with CMS were in his capacity as a consulting expert and thus privileged under Rule 26(b)(4)(D) of the Federal Rules of Civil Procedure. (Id. at 42948.) Humana replied that it had not agreed to excluding the communications from Relator’s privilege log and contested Relator’s claim of privilege. (Id. at 42947.) After several additional exchanges, the Parties reached an impasse, and on August 20, 2020, Humana contacted the Court to request leave to proceed to motion practice. (DN 379-15 at 42952-53.) On August 31, 2022, the undersigned ordered Relator to produce (1) a supplemental privilege log, (2) any nonprivileged documents related to communications with the DOJ and CMS

2 as requested by Humana’s requests for productions (“RFPs”) 7 and 9, (2) a supplemental response to Interrogatories 19 and 20 with respect to those communications, and (3) Foster for a deposition limited to the topic of Foster’s communications with the DOJ and CMS concerning this case. (DN 470 at 64871.) Relator filed an objection to the portion of that Order requiring a supplemental deposition, arguing that Foster’s communications with the government are privileged work

product under Federal Rule of Civil Procedure 26(b)(3) and (4). (See DN 474.) On June 30, 2022, United States District Judge Gregory N. Stivers overruled Relator’s objections and ordered Relator to produce Foster for a supplemental deposition and supplement his privilege log in accordance with the August 31, 2022 order. (See DN 502.) In a series of emails between September 7, 2022 and September 16, 2022 that began with a discussion about Foster’s availability for deposition before the September 28, 2022 deadline, Relator and Humana again disagreed on whether certain areas of inquiry were privileged under Fed. R. Civ. P. Rule 26 pursuant to the Court’s August 31, 2022 and June 22, 2022 orders. (DNs 520-3, 520-4.) In these communications, Humana also requested Relator supplement his privilege log entries and produce a document

(RELATOR_PRIV_479) identified on the log. (DN 520 at 66484.) Relator declined to produce RELATOR_PRIV_479 or produce Foster until the “parties can resolve any outstanding privilege disputes.” (Id.) On September 21, 2022, Relator served his privilege log, supplemented with entries for (1) attachments received or sent by CMS or HHS personnel and (2) attachments relating to work performed by Foster and shared with the government concerning this case, and filed the instant motion. (Id.) On September 29, 2022, Relator served a further amended privilege log that contained previously withheld attachments exchanged with government officials. (DN 520-1 at 66497.)

3 II. LEGAL STANDARD Under Rule 26(b), “[p]arties may obtain discovery regarding any nonprivileged matter that is relevant to any party's claim or defense and proportional to the needs of the case....” Fed. R. Civ. P. 26(b)(1). The “scope of discovery under the Federal Rules of Civil Procedure is traditionally quite broad.” Meredith v. United Collection Bureau, Inc., 319 F.R.D. 240, 242 (N.D. Ohio 2017)

(quoting Lewis v. ACB Bus. Serv., Inc., 135 F.3d 389, 402 (6th Cir. 1998)). Rule 26(c) allows the Court to issue protective orders for good cause shown to protect a party or person from annoyance, embarrassment, oppression, or undue burden or expense, including that the disclosure or discovery not be had or that the disclosure or discovery be limited to certain matters. Fed. R. Civ. P. 26(c). The party seeking the protective order bears the burden of showing that good cause exists for the order. Peterson v. Outback Steakhouse, 2016 U.S. Dist. LEXIS 129596, *3 (E.D. Mich. Sept. 22, 2016) (citing Nix v. Sword, 11 F. App’x 498, 500 (6th Cir. 2001)). “To show good cause, a movant for a protective order must articulate specific facts showing a ‘clearly defined and serious injury’ resulting from the discovery sought and cannot rely on mere conclusory statements.” Id. (citation

omitted). Mere speculation or unsubstantiated fears of prejudice are insufficient to justify the imposition of a protective order burdening a party's trial preparation. Nemir v. Mitsubishi Motors Corp., 381 F.3d 540, 550-551 (6th Cir. 2004) (“If [the movant's] unsubstantiated fears of prejudice justified a protective order, such orders would be justified in virtually every case”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States of America v. Humana Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-v-humana-inc-kywd-2023.